Barclays PLC Uni Qure N.V. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Barclays PLC holds 2,669 shares of QURE stock, worth $43,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,669

Previous 2,669 -0.0%

Holding current value

$43,050

Previous $13,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$3.78 - $10.12 $5,877 - $15,736	1,555 Added 139.59%	2,669 $13,000
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $1,374 - $1,699	-313 Reduced 21.93%	1,114 $5,000
Q1 2024 May 15, 2024	SELL	$4.82 - $6.93 $713,562 - $1.03 Million	-148,042 Reduced 99.05%	1,427 $7,000
Q4 2023 Feb 15, 2024	SELL	$5.63 - $8.27 $4.73 Million - $6.95 Million	-840,093 Reduced 84.9%	149,469 $1.01 Million
Q3 2023 Nov 07, 2023	BUY	$6.71 - $11.83 $5.58 Million - $9.84 Million	831,929 Added 527.76%	989,562 $6.64 Million
Q2 2023 Aug 03, 2023	BUY	$11.12 - $22.2 $1 Million - $2 Million	90,148 Added 133.58%	157,633 $1.81 Million
Q1 2023 May 04, 2023	SELL	$18.7 - $23.07 $739,772 - $912,649	-39,560 Reduced 36.96%	67,485 $1.36 Million
Q4 2022 Feb 13, 2023	SELL	$18.12 - $27.32 $575,219 - $867,273	-31,745 Reduced 22.87%	107,045 $2.43 Million
Q3 2022 Nov 03, 2022	BUY	$16.98 - $25.54 $2.2 Million - $3.3 Million	129,286 Added 1360.33%	138,790 $2.6 Million
Q2 2022 Aug 12, 2022	SELL	$13.15 - $20.45 $182,982 - $284,561	-13,915 Reduced 59.42%	9,504 $177,000
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $292,297 - $432,214	20,103 Added 606.24%	23,419 $424,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $369,258 - $656,966	-18,244 Reduced 84.62%	3,316 $69,000
Q3 2021 Nov 09, 2021	BUY	$26.01 - $38.22 $532,736 - $782,822	20,482 Added 1900.0%	21,560 $690,000
Q2 2021 Aug 13, 2021	SELL	$29.97 - $37.17 $275,124 - $341,220	-9,180 Reduced 89.49%	1,078 $33,000
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $17,690 - $25,428	-605 Reduced 5.57%	10,258 $346,000
Q4 2020 Feb 11, 2021	BUY	$35.35 - $50.67 $16,826 - $24,118	476 Added 4.58%	10,863 $392,000
Q3 2020 Nov 12, 2020	SELL	$35.98 - $47.66 $89,914 - $119,102	-2,499 Reduced 19.39%	10,387 $382,000
Q2 2020 Aug 12, 2020	BUY	$45.06 - $67.74 $580,643 - $872,897	12,886 New	12,886 $581,000
Q1 2020 May 13, 2020	SELL	$40.01 - $73.97 $840 - $1,553	-21 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$37.13 - $74.62 $296,297 - $595,467	-7,980 Reduced 99.74%	21 $2,000
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $39 - $76	1 Added 0.01%	8,001 $315,000
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $107,630 - $167,667	-2,040 Reduced 20.32%	8,000 $625,000
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $214,135 - $534,829	7,818 Added 351.85%	10,040 $598,000
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $1,162 - $1,730	51 Added 2.35%	2,222 $64,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $522,439 - $756,527	-17,561 Reduced 89.0%	2,171 $80,000
Q2 2018 Aug 14, 2018	SELL	$21.96 - $39.94 $604,053 - $1.1 Million	-27,507 Reduced 58.23%	19,732 $745,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $388,101 - $603,940	-22,696 Reduced 32.45%	47,239 $1.11 Million
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $477,761 - $988,315	50,450 Added 258.92%	69,935 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$7.7 - $9.6 $150,034 - $187,056	19,485	19,485 $187,000

Others Institutions Holding QURE

# of Institutions

156

Shares Held

40.5M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $754M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account